In the high-stakes world of corporate power and political manipulation, few revelations strike as deeply as the allegation that Pfizer executives deliberately slowed COVID-19 vaccine trials to influence the 2020 U.S. election. Newly uncovered testimony suggests that top Pfizer R&D leaders orchestrated a delay in clinical testing—not for scientific caution, but to ensure results wouldn’t emerge before Election Day. This bombshell, revealed through congressional investigations, paints a damning picture of a pharmaceutical giant willing to play god with public health for political and financial gain. The implications are staggering: a company entrusted with saving lives instead weaponized its science, suppressed critical data, and helped shape an election that led to unprecedented medical coercion.
Key points:
- Congressional investigators allege Pfizer intentionally slowed vaccine trials to avoid influencing the 2020 election.
- Former Pfizer scientist Dr. Philip Dormitzer reportedly admitted the delay was orchestrated by senior R&D leaders.
- The timing allowed Pfizer to avoid scrutiny before the election, then rapidly deploy mandates under a new administration.
- The scheme backfired as vaccine failures and injuries mounted, exposing the fraud behind the rushed approvals.
- The investigation raises urgent questions about corporate collusion, government corruption, and the erosion of medical ethics.
The election interference playbook
The 2020 presidential race was already one of the most contentious in U.S. history, with COVID-19 lockdowns, mask mandates, and promises of a “miracle” vaccine dominating the national conversation. Internal documents and whistleblower testimony now suggest Pfizer executives saw an opportunity—not to serve public health, but to exploit it. According to GSK’s testimony to Congress, Dr. Philip Dormitzer, a former Pfizer R&D leader, revealed that the company’s top three scientists deliberately slowed trial progress to avoid releasing data before November.
Dr. Dormitzer had told GSK employees that “in late 2020, the three most senior people in Pfizer R&D were involved in a decision to deliberately slow down clinical testing so that it would not be complete prior to the results of the presidential election that year.”
This wasn’t about scientific rigor—it was about political timing. Had Pfizer released results in October, then-President Donald Trump could have claimed credit for Operation Warp Speed, potentially swaying voters eager for an end to pandemic restrictions. Instead, Pfizer’s calculated delay left the public in limbo, fueling frustration and anger that Democrats weaponized against Trump. By the time the vaccine was unveiled under the Biden administration, the groundwork had been laid for aggressive mandates, despite mounting evidence of the shot’s inefficacy and risks.
Hellbound and Down 
You must be logged in to post a comment.